drug

silevertinib

Phase 2updated 5mo ago

by $BDTX Black Diamond Therapeutics, Inc.

Phase 2

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying silevertinib

phase2Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIrecruitingn=162
phase2Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutationsactive not recruitingn=200

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 27m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

drug

save

silevertinib

Phase 2updated 5mo ago

by $BDTX Black Diamond Therapeutics, Inc.

Phase 2

community read0 votes

indications

NSCLC

all catalysts(0)

nothing on the calendar yet

Trials studying silevertinib

phase2Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIIIrecruitingn=162
phase2Phase 1/2 Study of Silevertinib (BDTX-1535) in Patients With Glioblastoma or Non-Small Cell Lung Cancer With EGFR Mutationsactive not recruitingn=200

News(0)

no news has mentioned this drug yet

Data sources

ClinicalTrials.gov

last refreshed 27m ago

Found something off?

comments(0)

5-min edit window · permanent after that

no comments yet — first sniff?

silevertinib

indications

all catalysts(0)

Trials studying silevertinib

News(0)

Report a data issue

comments(0)

silevertinib

indications

all catalysts(0)

Trials studying silevertinib

News(0)

Report a data issue

comments(0)